Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on HANNOVER RUECK SE. We currently have 6 research reports from 1 professional analysts.
Frequency of research reports
Research reports on
HANNOVER RUECK SE
HANNOVER RUECK SE
Strong Q3 profit and boring 2017 targets released
10 Nov 16
Net income attributable to shareholders increased by 20% to €304m for Q3 16 versus Q3 15. Gross written premiums declined by 4% to €4.2bn for Q3 16 versus the same period last year. At constant exchange rates, it would have been a decrease of around 2%. Net premiums were down by 5.5% to €3.6bn for Q3 16. Net investment income came down by 6% to €402m in Q3 16. Total revenues declined by 5% to €4.0bn in Q3 16. Insurance claims decreased by 2% to €2.8bn for Q3 16 versus Q3 15. Total expenses came down by 8% to €3.55bn for Q3 16. Pre-tax income rose by 11% to €426m for Q3 16 versus the same period last year. The tax ratio was 26% in Q3 16 compared to 30% in Q3 15. Shareholders’ equity was up by 9% to €8.8bn at the end of September 2016 versus the end of 2015. The return on equity was 14.1% for Q3 16 and 13.2% for Q3 15. Net income attributable to shareholders was nearly unchanged at €790m for 9M 16 versus 9M 15. Hannover Re confirmed its full-year net income target of at least €950m for FY2016. Hannover Re released its outlook for FY2017, targeting a RoI of 2.7% and to post group net income in excess of €950m.
Weaker Q2 figures
04 Aug 16
Net income attributable to shareholders decreased by 15% to €214m for Q2 16 versus Q2 15. Gross written premiums declined by 4% to €4.0bn for Q2 16 versus the same period last year. At constant exchange rates, it would have been a decrease of around 2%. Net premiums were up by 1% to €3.6bn for Q2 16 due to a higher retention ratio. Net investment income was down by 1% to €379m in Q2 16. Total revenues rose by 1% to €4.0bn in Q2 16. Insurance claims declined by 3% to €2.6bn for Q2 16 versus Q2 15. Total expenses came up by 1% to €3.7bn for Q2 16. Pre-tax income declined by 5% to €321m for Q2 16 versus the same period last year. Shareholders’ equity was up by 4% to €8.4bn at the end of June 2016 versus the end of 2015. The return on equity was 10.2% for Q2 16 and 12.5% for Q2 15. Net income attributable to shareholders decreased by 9% to €486m for H1 16 versus H1 15. Hannover Re said it is well on track to achieve its full-year net income target of at least €950m for FY2016.
Solid Q1 figures, better P&C and weaker life & health results
10 May 16
Net income attributable to shareholders decreased by 3% to €271m for Q1 16 versus Q1 15. Gross written premiums were down by 3.1% to €4.26bn for Q1 16 versus the same period last year. At constant exchange rates the decline would have been 2.1%. Net investment income was down by 12% to €366m in Q1 16. Total revenues rose by 2% to €3.9bn in Q1 16. Insurance claims decreased by 1% to €2.7bn for Q1 16 versus Q1 15. Total expenses were up by 2% to €3.5bn for Q1 16. Pre-tax income declined by 4% to €389m for Q1 16 versus the same period last year. The tax rate came down from 31% for Q1 15 to 26% for Q1 16. Shareholders’ equity was up by 4% to €8.4bn at the end of March 2016 versus the end of 2015. The return on equity was 13.2% for Q1 16 and 13.9% for Q1 15. The solvency II ratio was 221%.
Another best financial year in the company's history
10 Mar 16
Net income attributable to shareholders increased by 17% to €1.15bn for FY2015 compared to FY2014. Net premiums earned were up by 17.5% to €14.6bn in the same period and up by 8% at constant currency. Net investment income rose by 13% to €1.67bn for FY2015 compared to FY2014. The RoI was slightly up at 3.5% for 2015 compared to 3.3% for 2014. Total revenues increased by 17% to €16.3bn. Total technical expenses rose by 16.5% to €14.5bn for FY2015. Net major loss expenditure was up from €426m for FY2014 to €573m for FY2015 but was clearly below the budgeted €690m for 2015. The pre-tax profit rose by 22% to €1.67bn for 2015. The tax ratio increased from 22% for FY2014 to 27% for FY2015. Shareholders’ equity was up by 7% to €8.07bn in 2015. RoE after tax was unchanged at 14.7% for 2015. The dividend proposal per share increased to €3.25 plus a special dividend of €1.50 for FY2015 compared to €3.00 plus €1.25 for FY2014.
Solid Q3 results, 2016 targets released
04 Nov 15
Pre-tax profit was flat at €383m for Q3 15 compared to Q3 14. Net premiums earned rose by 21.9% to €3.8bn for Q3 15 compared to the same period last year, the increase should be around 10% at constant currency. Net investment income was up by 3% to €426m in Q3 15 compared to Q3 14. Insurance claims rose by 20% to €2.86bn for Q3 15 compared to Q3 14. Total expenses were up by 21.9% to €4.23bn for Q3 15. The tax ratio for Q3 15 was 30% compared to 27% for Q3 14. Net income attributable to shareholders rose by 1% to €254m for Q3 15 compared to Q3 14. Shareholders' equity was up by 2.5% to €7.7bn at the end of September 2015 compared to the end of 2014. The return on equity after tax was 13.7% for 9M 15 and 14.4% for 9M 14. Hannover Re released its outlook for FY2016, targeting a RoI of 2.9% and to post group net income of around €950m.
Profit target upgraded to a more realistic level
05 Aug 15
Net income attributable to shareholders increased by 19% to €252m for Q2 15 versus Q2 14. Gross written premiums rose 22% to €4.2bn for Q2 15 versus the same period last year. At constant exchange rates, it would have been an increase of around 10%. Net investment income was up by 10% to €383m in Q2 15. Total revenues were up 21% to €4.0bn in Q2 15. Insurance claims rose by 21.5% to €2.7bn for Q2 15 versus Q2 14. Total expenses came up by 24% to €3.6bn for Q2 15. Pre-tax income rose by 8% to €360m for Q2 15 versus the same period last year. Shareholders' equity was up by 20% to €7.7bn at the end of June 2015 versus the end of June 2014. The return on equity was 12.5% for Q2 15 and 13.3% for Q2 14. Net income attributable to shareholders increased by 20% to €532m for H1 15 versus H1 14. Hannover Re increased its expectation for the FY2015 from the original level of €875m to a figure in the order of €950m.
Making Mobiles Better
17 Jan 17
Mobile phones are increasingly the key connection for the modern world. This means that the performance of mobile phones, and their networks, is going to become more critical for all the apps and businesses that rely on them. New technologies such as VR, AR, and AV will need better, more reliable connections to really move into the mainstream. In this thematic piece we attempt to identify some of the most important issues facing mobile phone networks and their users, and start to identify solutions and enablers that will solve these problems and create value by doing so.
The Monthly January 2017
09 Jan 17
Despite all the hullaballoo of the Brexit vote and the subsequent election of Donald Trump as the next US President, the UK stock market prospered last year, especially in the latter few months of 2016. The combination of a depreciating currency – making $ earnings more valuable in relative terms - and the Trump emphasis on infrastructure expenditure drove the stock market higher
Small Cap Breakfast
17 Jan 17
Global Energy Development (GED.L) — To be renamed Nautilus Marine Services. Schedule 1 from developer and seller of hydrocarbons and related products. Reverse takeover. Raising $10.5m via a convertible. Expected 9 Feb. Eco (Atlantic) Oil & Gas—TSX-V listed oil and gas exploration has announced its intention to float on AIM. Assets in Guyana and Namibia. Proposed £2m-£3m fundraise. Diversified Gas & Oil—According to LSE website first day of trading on AIM now expected for 30 January.
N+1 Singer - Best Ideas 2017 - Top picks
04 Jan 17
Today we publish our Best Ideas for 2017 - 12 stocks that we believe have excellent prospects in the current year together with a detailed discussion of what we see as the key sector and market themes for 2017. Our top picks are Cineworld, Elementis, Herald Investment Trust, Hill & Smith, IQE, MySale, Redde, ReNeuron, RhythmOne, SDL, Servelec and Severfield.
N+1 Singer - Morning Song 16-01-2017
16 Jan 17
As the birthplace of Stephenson, Armstrong and Swan, the North East of England has a proud history of industrial and technological innovation. Despite local economic challenges, the region’s industrial heritage lives on through continuing success in high end engineering and technology. The recent takeovers of private equity backed SMD (subsea robotics) and Nomad Digital (wi-fi on the railways) are testament to this. The North East has also emerged as a leader in genetics and genomics with an enviable life sciences and healthcare infrastructure. Against this backdrop, we expect the region to continue to throw up attractive IPO candidates to build on the six new listings in the past three years. We expect 2017 to be far kinder to the existing portfolio of North East plcs than 2016 (a year to forget) with recent management changes one important theme for the new year. Our top picks are Hargreaves Services, Quantum Pharma and Zytronic (all N+1 Singer Corporate clients) and we are Buyers of Northgate and Grainger.
N+1 Singer - Morning Song 19-01-2017
19 Jan 17
Actual Experience (ACT LN) 2017 – a milestone year for revenue | Bagir Group (BAGR LN) Independent NED appointment to strengthen Board composition | Bioquell (BQE LN) Reassuring pre-close statement | Carador Income Fund (CIFU LN) Q4 dividend increased to 2.75c, 0.5c higher than forecast | FreeAgent (FREE LN) Contract with Royal Bank of Scotland | Halfords Group (HFD LN) Excellent Q3 update, special divi and confidence in FX mitigations | N Brown Group (BWNG LN) Robust peak trading with reversal of drag from older titles | NCC Group (NCC LN) Interims confirm underlying business sound | St Ives (SIV LN) Downgrade | Summit Therapeutics (SUMM LN) Dr David Roblin appointed Chief Operating Officer and R&D President | Wilmington Group (WIL LN) Acquisition – Further scaling of Healthcare